血管加压素的心血管效应与临床应用研究进展(6)
[23] Achleitner U，Wenzel V，Strohmenger H U，et al.The effects of repeated dose of vasopressin or epinephrine on ventricular fibrillation in a porcine model of prolonged cardiopulmonary resuscitation[J].Anesth Analg，2000，90(5)：1067-1075.
[24] Wenzel V，Lindner K H.Arginine vasopressin during cardiopulmonary resuscitation：laboratory evidence，clinical experience and recommendations and a view to the future[J].Crit Care Med，2002，30(4)：157-161.
[25]杜昌辉.肾上腺素联合血管加压素心肺复苏中的应用[J].新疆医学，2009，39(7)：58-60.
[26] Wenzel V，Krismer A C，Voelckel W G，et al.The use of arginine vasopressin during cardiopulmonary resuscitation.Analysis of experimental and clinical experience and a view of the future[J].Anaesthesia，2002，51(3)：191-202.
[27] Nozari A，Rubertsson S，Willdund L，et al.Differences in the phamacodymamics of epinephrine and Vasopressin during and after experimental cardiopulmonary resustitation[J].Resustitation，2001，49(1)：59-72.
[28] Stiell I G，Hébert P C，Wells G A，et al.Vasopressin versus epinephrine for inhospital cardiac arrest：a randomised controlled trial[J].Lancet，2001，358(9276)：105-109.
[29] Asfar P，Hauser B，Ivanyi Z，et al.Low-dose terilipressin during long-term hyperdynamic porcine endotoxemia：effects on hepatosplanchnic perfusion，oxgen exchange，and metabolism[J].Crit Care Med，2005，33(2)：373-380.
[30] Holmes C L，Patel B M，Russell J A，et al.Physiology of vasopressin relevant to management of septic shock[J].Chest，2001，120(3)：989-1002.
[31] Nnrayen G，Mandal S N.Vasnpressin receptor antagonists and their role in clinical medicine[J].Indian J Endocrinol Metab，2012，16(2)：183-191.
(收稿日期：2017-09-15) (本文編辑：程旭然), 百拇医药(韦有全 黄海清)
[24] Wenzel V，Lindner K H.Arginine vasopressin during cardiopulmonary resuscitation：laboratory evidence，clinical experience and recommendations and a view to the future[J].Crit Care Med，2002，30(4)：157-161.
[25]杜昌辉.肾上腺素联合血管加压素心肺复苏中的应用[J].新疆医学，2009，39(7)：58-60.
[26] Wenzel V，Krismer A C，Voelckel W G，et al.The use of arginine vasopressin during cardiopulmonary resuscitation.Analysis of experimental and clinical experience and a view of the future[J].Anaesthesia，2002，51(3)：191-202.
[27] Nozari A，Rubertsson S，Willdund L，et al.Differences in the phamacodymamics of epinephrine and Vasopressin during and after experimental cardiopulmonary resustitation[J].Resustitation，2001，49(1)：59-72.
[28] Stiell I G，Hébert P C，Wells G A，et al.Vasopressin versus epinephrine for inhospital cardiac arrest：a randomised controlled trial[J].Lancet，2001，358(9276)：105-109.
[29] Asfar P，Hauser B，Ivanyi Z，et al.Low-dose terilipressin during long-term hyperdynamic porcine endotoxemia：effects on hepatosplanchnic perfusion，oxgen exchange，and metabolism[J].Crit Care Med，2005，33(2)：373-380.
[30] Holmes C L，Patel B M，Russell J A，et al.Physiology of vasopressin relevant to management of septic shock[J].Chest，2001，120(3)：989-1002.
[31] Nnrayen G，Mandal S N.Vasnpressin receptor antagonists and their role in clinical medicine[J].Indian J Endocrinol Metab，2012，16(2)：183-191.
(收稿日期：2017-09-15) (本文編辑：程旭然), 百拇医药(韦有全 黄海清)